Patented drugs price review could impact innovation

Andrew Skodyn was mentioned in the Law Times article "Patented drugs price review could impact innovation". HHe discusses the federal government’s recently proposed changes to the PMPRB and how they may impact the pharmaceutical industry in Canada.